<DOC>
	<DOC>NCT00651963</DOC>
	<brief_summary>Gather additional efficacy and safety (pharmacovigilance) information in the usual daily care in patients with Dyslipidemia on ezetimibe under real conditions in Colombia associated with statins.</brief_summary>
	<brief_title>Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>&gt; 18 years old Lipid Metabolic Disorder as Per ATP III who have not reached the goals and who are on statins for at least 4 weeks Or those who require LDL reductions Over 50% to reach the ATP III goals or who need statins in accordance their risk score Pregnancy, Breast Feeding Moderate/Sever Liver Disease: Child Score &gt; Or = To 7 Fibrates Terminal Disease Contraindications To Receive ezetimibe Contraindications To Receive Statins Mental Disability Hypersensitivity To ezetimibe On another Clinical Research Trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>